An observational study in Cataract, sponsored by Jin Yang. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-19.
Sponsored by Jin Yang · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 184 studies in Cataract with a site in China — 39 open to participants now, 49 under way, none of them phase 3. Cataract · China.
Among the 184 studies in Cataract with a site in China, this one is the 44th largest by planned enrollment of the 73 observational ones that give a count, is one of 15 that started in 2025, is one of 73 observational ones, reaches primary completion later than 44 of the 48 other live ones, and was the 162nd registered.
1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.
Browse Cataract studies →39 of the 184 studies in Cataract with a site in China are open now. Recruiting first, the newest first:
Zhongshan Ophthalmic Center, Sun Yat-sen University · Sites in China
Ages 18–90
Nanfang Hospital, Southern Medical University · Sites in China
Ages 40–85
Second Affiliated Hospital, School of Medicine, Zhejiang University · Sites in China
Ages 18+
Nanfang Hospital, Southern Medical University · Sites in China
Ages 18–90
Zhongshan Ophthalmic Center, Sun Yat-sen University · Sites in China
Ages 50–90
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
184 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 15 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 90 across 477 observational studies indexed under Cataract.
Median enrollment 90 across the 111 interventional studies, 120 across the 73 observational. Of the 80 that completed or were terminated, 9 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 184 have an industry lead sponsor. The 10 most frequent:
Jin Yang is the lead sponsor of 7 studies on the registry; 6 are open to participants now.
Jin Yang has 6 studies filed under Cataract — fewer than ten, so there is no comparison to draw.
7 of the studies in Cataract with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07713069Zhongshan Ophthalmic Center, Sun Yat-sen UniversityOCT-PRO Model vs. Clinicians: Cataract Surgery Outcome Prediction | 2026-11-30 |
| NCT02182921Evidence Based Cataract Study GroupEvaluation of Cataract Surgery Outcome | 2026-12 |
| NCT07550907Zhongshan Ophthalmic Center, Sun Yat-sen UniversityThe Impact of Surgical Procedures on Postoperative Outcomes in Cataract Phacoemulsification and Analysis of Related Factors | 2026-12-31 |
| NCT07733154The Hong Kong Polytechnic UniversityAI-Driven IOL Prediction Using SS-OCT Biometry | 2027-03-20 |
| NCT07126470Zhongshan Ophthalmic Center, Sun Yat-sen UniversityImpact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients | 2027-08 |
Add all 7 to your calendar (.ics) → With an account.
Among the 184 studies in Cataract with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
We conducted a single-center, retrospective observational study to evaluate large language models (ChatGPT 4o, GPT-5, DeepSeek) for automated interpretation of de-identified IOLMaster 700 reports provided as raster images. Models produced structured biometric extraction, toric IOL recommendation, and refractive predictions (sphere, cylinder, axis). Primary outcomes included parameter-level agreement and refractive error metrics; secondary outcomes included decision-support performance for toric IOL selection and agreement on ordered T-codes. No clinical intervention was performed.
This study compares three large language models accessed in their native configurations, without fine-tuning or external tools. For each examination, the original IOLMaster 700 report image was supplied without manual annotation or pre-processing. A standardized instruction required: (i) structured extraction of AL, ACD, LT, WTW, K1/K2 and axes, ΔK, TK1/TK2 and axes, and ΔTK; (ii) binary toric candidacy and T-code according to institutional ALCON mapping; and (iii) refractive recommendations (sphere, cylinder, implantation axis). Each model generated three independent outputs per case. De-identification and IRB oversight (waiver of consent) were implemented according to institutional policy. The unit of enrollment is participants (n=54), with outcomes analyzed per eye (162 eyes) and per model generation where applicable.
cataract patients who had undergone phacoemulsification and implantation of an AcrySof IQ Toric monofocal intraocular lens
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
-postoperative corrected distance visual acuity (CDVA) of 0.10 logMAR or better -an absolute IOL rotational stability of less than 10∘ at the 1-month follow-up examination
Exclusion Criteria:
Refractive prediction error for sphere
Mean absolute error (MAE, diopters) of model-predicted sphere versus clinical reference
Time frame: At index examination
Cohen's kappa with 95% CIs between model
Cohen's kappa with 95% CIs between model outputs and clinician-validated reference for per-parameter
Time frame: At index examination (single time point)
Cylinder prediction error
Mean absolute error (MAE, diopters) of model-predicted Cylinder
Time frame: At index examination
Axis prediction error
Mean absolute error (MAE, diopters) of model-predicted Axis
Time frame: At index examination
Plan to share: No
No publications or documents are linked to this record.
Started Aug 2025 (actual). Primary completion is estimated for Dec 2030, 64 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Jin Yang